Domantis, GlaxoSmithKline deal

By WIR Staff | Dec 11, 2006 | 8:00 AM GMT

GSK will acquire domain antibody company Domantis for £230 million ($455

Read the full 118 word article

How to gain access

Continue reading with a
two-week free trial.